Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1491
https://www.valueinhealthjournal.com/article/S1098-3015(17)31825-9/fulltext
Title :
Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31825-9&doi=10.1016/j.jval.2017.08.1491
First page :
A645
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1338